Screener
AbbVie ABBV EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from AbbVie’s reported figures.
Based on trailing twelve months.
The source filing: AbbVie’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
FAQ
- What is AbbVie's EBITDA margin?
- AbbVie (ABBV) reported EBITDA margin of 37.3% in Q1 2026.
- What is the long-term trend for AbbVie's EBITDA margin?
- Over 4 years (2020 to 2025), AbbVie's EBITDA margin has grown at a -0.5% compound annual growth rate (CAGR), from 38.9% to 38.1%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about AbbVie's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude